WCN26-6022 PARTIAL REMISSION, COMPLETE REMISSION, AND RELAPSE IN PATIENTS WITH PRIMARY MEMBRANOUS GLOMERULOPATHY AT 24 MONTHS OF TREATMENT WITH TWO RITUXIMAB REGIMENS
20260 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 0.00
WCN26-6022 PARTIAL REMISSION, COMPLETE REMISSION, AND RELAPSE IN PATIENTS WITH PRIMARY MEMBRANOUS GLOMERULOPATHY AT 24 MONTHS OF TREATMENT WITH TWO RITUXIMAB REGIMENS | Researchclopedia